Sign Up to like & get
recommendations!
0
Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab096.005
Abstract: Recently, we demonstrated the efficacy of etelcalcetide for control of secondary hyperparathyroidism (SHPT) in the DUET trial; a 12-week multicenter, open-label, randomized (1:1:1), parallel-group study treated with etelcalcetide + active vitamin D (Group E+D), etelcalcetide…
read more here.
Keywords:
active vitamin;
trial;
group;
calcium preparation ... See more keywords